Biomarker for Rapid Diagnosis of Hemispheric Stroke
Biomarker for Rapid Diagnosis of Hemispheric Stroke
The aim of the study is to estimate the diagnostic accuracy of a combined biomarker test (including NMDA-Receptor fragments [NR2-peptide] and Glial fibrillary acidic protein) used to differentiate between cerebral ischemia and intracerebral hemorrhage in patients with acute hemispheric stroke.
Inclusion Criteria:
Exclusion Criteria: